Abstract |
This study aimed to develop a mucoadhesive polymeric excipient comprising curcumin for buccal delivery. Curcumin encompasses broad range of benefits such as antioxidant, anti-inflammatory, and chemotherapeutic activity. Hyaluronic acid (HA) as polymeric excipient was modified by immobilization of thiol bearing ligands. L-Cysteine (SH) ethyl ester was covalently attached via amide bond formation between cysteine and the carboxylic moiety of hyaluronic acid. Succeeded synthesis was proved by H-NMR and IR spectra. The obtained thiolated polymer hyaluronic acid ethyl ester (HA-SH) was evaluated in terms of stability, safety, mucoadhesiveness, drug release, and permeation-enhancing properties. HA-SH showed 2.75-fold higher swelling capacity over time in comparison to unmodified polymer. Furthermore, mucoadhesion increased 3.4-fold in case of HA-SH and drug release was increased 1.6-fold versus HA control, respectively. Curcumin-loaded HA-SH exhibits a 4.4-fold higher permeation compared with respective HA. Taking these outcomes in consideration, novel curcumin-loaded excipient, namely thiolated hyaluronic acid ethyl ester appears as promising tool for pharyngeal diseases.
|
Authors | Flavia Laffleur, Franziska Schmelzle, Ariane Ganner, Stefan Vanicek |
Journal | AAPS PharmSciTech
(AAPS PharmSciTech)
Vol. 18
Issue 6
Pg. 2102-2109
(Aug 2017)
ISSN: 1530-9932 [Electronic] United States |
PMID | 28028792
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Animals
- Caco-2 Cells
- Curcumin
(administration & dosage, chemistry, pharmacokinetics)
- Drug Delivery Systems
(methods)
- Drug Evaluation, Preclinical
(methods)
- Excipients
(administration & dosage, chemistry, pharmacokinetics)
- Humans
- Mouth Mucosa
(drug effects, metabolism)
- Swine
|